Sagimet Biosciences Inc. (NASDAQ: SGMT) Stock Information | RedChip

Sagimet Biosciences Inc. (NASDAQ: SGMT) Listen to this Section


$2.75
-0.0100 ( -0.36% ) 250.1K

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Market Data


Open


$2.75

Previous close


$2.76

Volume


250.1K

Market cap


$87.76M

Day range


$2.70 - $2.87

52 week range


$2.13 - $20.71

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Apr 03, 2024
4 Insider transactions 1 Mar 28, 2024
10-k Annual reports 106 Mar 25, 2024
8-k 8K-related 49 Mar 25, 2024
8-k 8K-related 14 Feb 02, 2024
3 Insider transactions 2 Feb 02, 2024
4 Insider transactions 1 Jan 31, 2024
4 Insider transactions 1 Jan 31, 2024
4 Insider transactions 1 Jan 31, 2024
4 Insider transactions 1 Jan 31, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.